Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TerveystaloFRA:4TS +0.95%73 EV-to-OCF is 8.73 as of Sep. 01, 2026, which is 15% below its 10-year median of 10.32. GuruFocus rates FRA:4TS with a GF Score™ of 73/100 and a GF Value™ of €8.61 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Terveystalo ranks better than 51.39% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Terveystalo's Enterprise Value is €1,526 Mil.
Terveystalo's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €175 Mil. Therefore, Terveystalo's EV-to-OCF for today is 8.73.
The historical rank and industry rank for Terveystalo's EV-to-OCF or its related term are showing as below:
FRA:4TS'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.74 Med: 10.32 Max: 36.85
Current: 8.81
During the past 12 years, the highest EV-to-OCF of Terveystalo was 36.85. The lowest was 7.74. And the median was 10.32.
FRA:4TS's EV-to-OCF is ranked better than 51.39% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 9.1
vs FRA:4TS: 8.81
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Terveystalo's PE Ratio (TTM) for today is calculated as:
Terveystalo's share price for today is €7.42.
Terveystalo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Terveystalo EV-to-OCF Related Terms
Terveystalo EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Terveystalo's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Terveystalo's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terveystalo EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Terveystalo's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Terveystalo's EV-to-OCF falls into.
Terveystalo's current Enterprise Value is €1,526 Mil.
Terveystalo's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €175 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terveystalo (FRA:4TS) has a EV-to-OCF of 8.73 as of Sep. 01, 2026. This is 15% below median its historical median of 10.32. Over the past decade, Terveystalo's EV-to-OCF has ranged from 7.74 to 36.85. According to the industry distribution chart, Terveystalo ranks #333 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 48.6%.
Is Terveystalo's EV-to-OCF too high?
Terveystalo's current EV-to-OCF of 8.73 is 15% below median its 10-year median of 10.32. Over the past 10 years, this metric has ranged from a low of 7.74 to a high of 36.85. The Healthcare Providers & Services industry median EV-to-OCF is 9.10. Terveystalo's value of 8.73 is 4.1% below this industry median. Based on the distribution chart, Terveystalo ranks #333 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Terveystalo has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terveystalo's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Terveystalo ranks #333 out of 685 companies for EV-to-OCF. This puts Terveystalo in the upper half of its industry. The industry median EV-to-OCF is 9.10. Terveystalo's value of 8.73 is 4.1% below this benchmark. Historically, Terveystalo's own EV-to-OCF has ranged from 7.74 to 36.85 over the past decade. While the company's 10-year median is 10.32 vs. the industry median of 9.10, Terveystalo has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 9.10, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terveystalo's current EV-to-OCF of 8.73 is 4.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 9.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terveystalo's current EV-to-OCF is 8.73, which is 15% below median its own 10-year median of 10.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terveystalo stock overvalued right now?
Based on GuruFocus' analysis, Terveystalo (FRA:4TS) is currently considered Modestly Undervalued. The stock's GF Value™ is €8.61, compared to a current price of €7.42 — trading 13.8% below its estimated fair value. The current EV-to-OCF is 8.73, which is 15% below median its 10-year median of 10.32 and 4.1% below the Healthcare Providers & Services industry median of 9.10. Terveystalo's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Terveystalo (FRA:4TS), the current EV-to-OCF is 8.73 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terveystalo (FRA:4TS) Overvalued in 2026?
Based on GuruFocus' analysis, Terveystalo stock appears to be undervalued.
The current stock price of €7.42 is trading 13.8% below its estimated GF Value™ of €8.61.
GuruFocus considers Terveystalo to be Modestly Undervalued.
Key valuation signals for FRA:4TS:
EV-to-OCF: 8.73 (15% below median its 10-year median of 10.32)
GF Value™: €8.61 vs. price of €7.42 (13.8% below fair value)
Industry Position: 4.1% below the Healthcare Providers & Services median (#333 of 685)
No single metric tells the full story. See the FRA:4TS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. The healthcare service offering of the company includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
73GF Score
Get the complete analysis for FRA:4TS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4TS has been successfully added to your 
